Clinical Trial Update: Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for Narazaciclib (ON 123300) plus letrozole in endometrial cancer and other gynecologic malignancies (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrioid Endometrial Cancer

Drugs mentioned

• Letrozole (letrozole)
• Narazaciclib (ON 123300) (narazaciclib)

Snippet

Sponsor: Traws Pharma, Inc. | Conditions: Endometrioid Endometrial Cancer | Phase 1, Phase 2 | Status: UNKNOWN